Lab21 adds Susan Lowther as CFO
This article was originally published in Clinica
UK personalised medicine firm Lab21 has made Susan Lowther its CFO. Ms Lowther has previously held senior management positions at biopharma firms BioWisdom, RiboTargets and Lonza Biologics, biotech company Celltech and plant biotechnology expert Monsanto. She replaces Maddy Kennedy, who has become director at a consulting business focussed on supporting high-tech, entrepreneurial businesses through growth, funding and mergers and acquisitions called CFO4Growth. Cambridge-based Lab21 specialises in immunodiagnostic kits and reagents for the infectious disease and blood banking markets.